Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Mallinckrodt
US Department of Justice
Fuji
Deloitte
Boehringer Ingelheim
Cerilliant
Covington

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,077,843

« Back to Dashboard

Summary for Patent: 6,077,843
Title: Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
Abstract:The present invention is concerned with a pharmaceutical composition suitable as a depot formulation for administration via intramuscular or subcutaneous injection, comprising: (1) as an active ingredient a therapeutically effective amount of a 9-hydroxyrisperidone fatty acid ester or a salt, or a stereoisomer or a stereoisomeric mixture thereof and (2) a pharmaceutically acceptable carrier; wherein the pharmaceutically acceptable carrier is water and the active ingredient is suspended therein; and with a process of preparing such a composition. The invention further concerns such a pharmaceutical composition for use as a medicament in the treatment of schizophrenia, non-schizophrenic psychoses, behavioural disturbances associated with neurodegenerative disorders, e.g. in dementia, behavioural disturbances in mental retardation and autism, bipolar mania, depression, anxiety.
Inventor(s): Fran.cedilla.ois; Marc Karel Jozef (Kalmthout, BE), Embrechts; Roger Carolus Augusta (Oud-Turnhout, BE), Borghijs; Herman Karel (Willebroek, BE), Monbaliu; Johan (Turnhout, BE)
Assignee: Janssen Pharmaceutica, N.V. (Beerse, BE)
Application Number:09/180,659
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound; Process; Use;

Drugs Protected by US Patent 6,077,843

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,077,843

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
96 201 429May 20, 1996
PCT Information
PCT FiledMay 12, 1997PCT Application Number:PCT/EP97/02504
PCT Publication Date:November 27, 1997PCT Publication Number: WO97/44039

International Family Members for US Patent 6,077,843

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Czech Republic 291284 ➤ Try a Free Trial
Germany 69708284 ➤ Try a Free Trial
Germany 122011100027 ➤ Try a Free Trial
Denmark 0904081 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Queensland Health
Deloitte
AstraZeneca
McKesson
Moodys
Boehringer Ingelheim
UBS
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.